机构:[a]First Department of Head and Neck Surgery, The Third Affiliated Hospital of Kunming Medical University, Tumor Hospital of Yunnan Province, Kunming, Yunnan 650118, China[b]Department of Cancer Biotherapy Center, Tumor Hospital of Yunnan Province, Kunming, Yunnan 650118, China[c]Department of Pathology and Histotechnology, Tumor Hospital of Yunnan Province, Kunming, Yunnan 650118, China[d]Department of Gynecology, Tumor Hospital of Yunnan Province, Kunming, Yunnan 650118, China[e]Department of Medical Oncology, Tumor Hospital of Yunnan Province, Kunming, Yunnan 650118, China[f]Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
This work was supported in part by The National Natural Science Foundation of China, [#81760554]; The Applied Basic Research Foundation of Yunnan Province Science and Technology Department & Kunming Medical University of China [#2017FE468 (?211)], [#2017FE467(?083)], [#2018FE001(?059)], [#2018FE001(?061)], and [#2018FE001(?249)]; Scientific Research Foundation of Yunnan Provincial Education Department, [2016ZDX060].
语种:
外文
中科院(CAS)分区:
出版当年[2021]版:
大类|4 区生物
小类|4 区生物工程与应用微生物
最新[2023]版:
大类|4 区生物学
小类|4 区生物工程与应用微生物
第一作者:
第一作者机构:[a]First Department of Head and Neck Surgery, The Third Affiliated Hospital of Kunming Medical University, Tumor Hospital of Yunnan Province, Kunming, Yunnan 650118, China
通讯作者:
推荐引用方式(GB/T 7714):
Zhao L,Ge C,Zhang Z,et al.FAM136A immunoreactivity is associated with nodal involvement and survival in lung adenocarcinoma in a Chinese case series.(Open Access)[J].Bioengineered.2020,11(1):261-271.doi:10.1080/21655979.2020.1735611.
APA:
Zhao, L,Ge, C,Zhang, Z,Hu, H,Zhang, Y...&Li, G.(2020).FAM136A immunoreactivity is associated with nodal involvement and survival in lung adenocarcinoma in a Chinese case series.(Open Access).Bioengineered,11,(1)
MLA:
Zhao, L,et al."FAM136A immunoreactivity is associated with nodal involvement and survival in lung adenocarcinoma in a Chinese case series.(Open Access)".Bioengineered 11..1(2020):261-271